Company: HYEX
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001096906-25-001864
Chunk: 14

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 7
Chunk 14
---
 any similar regulatory body for safety and efficacy. Our mission is to acquire or create products with health and performance benefits that have mass consumer appeal.

Guided by this mission, our first two acquisitions formed our current operating subsidiaries, BergaMet NA, LLC, which offers nutraceutical heart and immune health products, and UBN, which offers nutraceutical products for brain health. Based on published research from third-party sources, we believe our BergaMet NA, LLC products have been shown to support heart health, support immune response, and address metabolic syndrome. 

Our Financial Condition and Going Concern Issues

Our net loss from inception to December 31, 2024 was $19,240,344, and we had limited cash resources at December 31, 2024 of $112,020. Our financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Our auditor’s report reflects that our ability to continue as a going concern is dependent upon our ability to raise additional capital from the sale of common stock or other means and, ultimately, the achievement of significant operating revenues. If we are unable to continue as a going concern, our business will fail and stockholders will lose their investment in our company. No assurance can be given that such financing will be available or, if available, that it will be on commercially favorable terms. Moreover, financing will likely be dilutive to our stockholders.

Results of Operations for the Three and Nine Months Ended September 30, 2025 and 2024

Introduction

We had revenues of $917,975 and $2,817,910 for the three and nine months ended September 30, 2025, compared to $744,916 and $2,342,091 for the three and nine months ended September 30, 2024. Our cost of revenue for the three and nine months ended September 30, 2025 were $470,725 and $1,352,848, compared to $142,456 and $845,185 for the three and nine months ended September 30, 2024.

Our operating expenses were $907,363 and $2,139,630 for the three and nine months ended September 30, 2025, compared to $517,068 and $1,485,945 for the three and nine months ended September 30, 2024. Our operating expenses consisted entirely of general and administrative expenses.

22

Our net